التفاصيل البيبلوغرافية
| العنوان: |
1494P Updated safety data of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma - A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK |
| المؤلفون: |
Al-Batran, S-E., Lorenzen, S., Thuss-Patience, P.C., Schenk, M., Goekkurt, E., Hofheinz, R.D., Kretzschmar, A., Heuer, V., Bolling, C., Haag, G.M., Angermeier, S., Fischer von Weikersthal, L., Bechstein, W.O., Wicki, A., Siebenhüner, A., Waberer, L., Irahara, N., Pauligk, C., Götze, T.O., Homann, N. |
| المصدر: |
In Annals of Oncology September 2020 31 Supplement 4:S927-S928 |
| قاعدة البيانات: |
ScienceDirect |
